- Home
- GLE vs ATHA Comparison
GLE vs ATHA Comparison
Compare GLE & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLE
- ATHA
- Stock Information
- Founded
- GLE 2018
- ATHA 2011
- Country
- GLE Hong Kong
- ATHA United States
- Employees
- GLE N/A
- ATHA N/A
- Industry
- GLE
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- GLE
- ATHA Health Care
- Exchange
- GLE NYSE
- ATHA Nasdaq
- Market Cap
- GLE 82.3M
- ATHA 21.0M
- IPO Year
- GLE 2024
- ATHA 2020
- Fundamental
- Price
- GLE $1.59
- ATHA $0.56
- Analyst Decision
- GLE
- ATHA Buy
- Analyst Count
- GLE 0
- ATHA 4
- Target Price
- GLE N/A
- ATHA $11.25
- AVG Volume (30 Days)
- GLE 134.7K
- ATHA 337.6K
- Earning Date
- GLE 02-23-2025
- ATHA 02-20-2025
- Dividend Yield
- GLE N/A
- ATHA N/A
- EPS Growth
- GLE N/A
- ATHA N/A
- EPS
- GLE 0.02
- ATHA N/A
- Revenue
- GLE $6,333,093.00
- ATHA N/A
- Revenue This Year
- GLE N/A
- ATHA N/A
- Revenue Next Year
- GLE N/A
- ATHA N/A
- P/E Ratio
- GLE $83.27
- ATHA N/A
- Revenue Growth
- GLE 10.67
- ATHA N/A
- 52 Week Low
- GLE $1.39
- ATHA $0.41
- 52 Week High
- GLE $5.44
- ATHA $4.30
- Technical
- Relative Strength Index (RSI)
- GLE N/A
- ATHA 51.11
- Support Level
- GLE N/A
- ATHA $0.51
- Resistance Level
- GLE N/A
- ATHA $0.60
- Average True Range (ATR)
- GLE 0.00
- ATHA 0.04
- MACD
- GLE 0.00
- ATHA 0.00
- Stochastic Oscillator
- GLE 0.00
- ATHA 78.39
About GLE GLOBAL ENGINE GROUP HOLDING LIMITED
Global Engine Group Holding Ltd offers integrated solutions by using ICT solutions to drive business outcomes and innovation. It serves primarily as a holding company for its operating subsidiary, Global Engine Limited. Its service offerings comprise services to telecom operators, including the one-stop shop purchase from telecom license application service to turnkey network setup as well as service outsourcing; business planning, development, technical and operations consulting programs structured to target the cloud computing and data center providers; system design, planning, development and operation services to technology companies; cloud platform deployment, IT system design and configuration services, maintenance services, data center colocation service and cloud service.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.